Table 1.
Profile of Fournier Gangrene Patients
| Group 1 (Survivor) n = 60 | Group 2 (Non-Survivor) n = 23 | P value | |
|---|---|---|---|
| Age | 49.86 ± 11.78 | 55.86 ± 13.56 | 0.059 |
| Physiological | |||
| GCS | 15 (14–15) | 15 (14–15) | 0.764 |
| MAP | 86.46 ± 22.35 | 75.79 ± 31.66 | 0.146 |
| Temperature | 37.39 ± 0.791 | 37.5 ± 0.634 | 0.441 |
| Respiratory rate | 21.63 ± 2.945 | 25.75 ± 5.972 | 0.000 |
| % Body surface area | 5.88 ± 2.472 | 5.66 ± 2.135 | 0.596 |
| Charlson Comorbidity Index | 2.5 (0–9) | 2 (1–8) | 0.005 |
| Comorbidity | |||
| Diabetes | 24 (40%) | 10 (43.5%) | 0.482 |
| Hypertension | 6 (10%) | 2 (8.7%) | 0.611 |
| HIV | 1 (1.7%) | 2 (8.7%) | 0.184 |
| Fistula | 2 (3.3%) | 2 (8.7%) | 0.306 |
| Abscess | 16 (26.7%) | 7 (30.4%) | 0.465 |
| Stricture | 1 (1.7%) | 1 (4.3%) | 0.480 |
| Malignancy | 0 (0%) | 3 (4.5%) | 0.298 |
| Heart disorder | 1 (4.3%) | 2 (3%) | 0.763 |
| Laboratory data | |||
| Hb | 11.87 ± 3.25 | 10.57 ± 3.00 | 0.362 |
| Ht | 33.84 ± 8.76 | 31.46 ± 8.72 | 0.272 |
| Leucocyte | 17,297.63 ± 8675.54 | 28,596.57 ± 45,612.76 | 0.071 |
| Thrombocyte | 382,847.46 ± 167,591.03 | 263,043.48 ± 147,134.9 | 0.003 |
| Sodium | 130.81 ± 5.81 | 128.70 ± 7.77 | 0.248 |
| Calcium | 4.55 ± 4.49 | 4.30 ± 1.03 | 0.694 |
| Urea | 65.01 ± 57.32 | 105.22 ± 65.45 | 0.014 |
| Creatinin | 2.12 ± 2.66 | 1.94 ± 1.06 | 0.658 |
| HCO3 | 26.7 ± 13.48 | 23.68 ± 12.27 | 0.336 |
| GDS | 176.87 ± 130.77 | 160.94 ± 88.68 | 0.566 |
| Albumin | 2.90 ± 1.76 | 2.16 ± 14.32 | 0.165 |
| Length of hospitalization | 25.5 (1–71) | 5 (2–31) | 0.000 |
| FGSI | 5.5 (2–15) | 14 (10–19) | 0.000 |
| < 9 | 42 (70%) | 1 (4.3%) | 0.000 |
| ≥ 9 | 18 (30%) | 22 (95.7%) | |
| <11 | 49 (81.6%) | 4 (17.3%) | |
| ≥11 | 11 (18.3%) | 19 (82.6%) | |
| ≥14 | 9 (15%) | 14 (60.8%) | |
| <14 | 51 (85%) | 9 (39.1%) | |
| qSOFA score | 0 (0–3) | 1 (0–3) | 0.007 |
| Other procedures | |||
| Colostomy | 3 (13%) | 8 (12.1%) | 0.908 |
| Cystostomy | 1 (4.3%) | 3 (4.5%) | 0.969 |
Note: Statistically significant (p<0.05).